The statistics are sobering. More than 6 million Americans have Alzheimer’s, the most common form of dementia, the progressive brain disorder that begins with mild memory loss and can progress to a loss of ability to talk or respond to the environment. Even the most chill older adult can’t help but worry at least a
0 Comments
TARRYTOWN, N.Y., June 4, 2021 /PRNewswire/ –  EUA supported by pivotal Phase 3 data showing 1,200 mg dose reduced risk of hospitalization or death by 70% Only antibody therapy currently available in all 50 states, including eight states with high rates of two variants of concern Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and
0 Comments
EAST HANOVER, N.J., June 1, 2021 /PRNewswire/ — Novartis, a leader in immuno-dermatology and rheumatology, today announced the U.S. Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of moderate to severe plaque psoriasis in pediatric patients six years and older who are candidates for systemic therapy or phototherapy1. This is the
0 Comments
Dr. Peter Hotez warned that Southern U.S. states could feel the impact of the highly transmissible Delta Covid variant as early as this summer, due in part to low vaccination rates.  “I’m really holding my breath about the South and what happens over the summer,” said Hotez, co-director of the Center for Vaccine Development at
0 Comments
Only one biomarker was useful in predicting the relapse of Crohn’s disease in children after anti-tumor necrosis factor (TNF)-α therapy, Korean researchers found in a retrospective observational study. At 1 year following anti-TNF-α therapy, albumin-to-globulin ratio (AGR) was the only marker associated with time-to-relapse in Crohn’s disease (HR 0.02, 95% CI 0.002-0.181, P<0.001), reported Yon
0 Comments
June is National Cancer Survivors Month! To honor survivors, we will be sharing stories from folks with cancer and their caregivers. Today we hear from Marlys. It was the sunny month of July. We were sharing a vacation rental with our daughter, son-in-law, and the grandkids in a nearby mountain village. My husband’s cancer was
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. It’s not just people coming out of lockdown: As COVID-19 restrictions ease and masks come off, as crowds gather and vacationers travel, viruses that had been reduced, in some cases to negligible threats, are reemerging. Some of the indications of fewer
0 Comments
Start them young, and stand by as their self-love and confidence blossoms Parents almost always teach their kids to be kind. They encourage them to say please and thank you, share their toys, and be a good friend. But self-kindness is often left unsaid, and in my role as a children’s therapist I’ve heard many
0 Comments
A year ago, when U.S. health authorities issued their first warning that COVID-19 would cause severe “disruption to everyday life,” doctors had no effective treatments to offer beyond supportive care. There is still no quick cure, but thanks to an unprecedented global research effort, several treatments are helping patients survive COVID-19 and stay out of
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Following a safety review, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has advised against use of the AstraZeneca’s Vaxzevria COVID-19 vaccine in people with a history of capillary leak syndrome. Capillary leak syndrome will be added
0 Comments
FDA Approves Prevnar 20 (pneumococcal 20-valent conjugate vaccine) for Adults Ages 18 Years or Older First approval of a conjugate vaccine that helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia,1,2,3,4,5,6,7 including seven responsible for 40% of pneumococcal disease cases and deaths in the U.S. Helps protect against more serotypes
0 Comments
Getty Images Some of the 12,000 attendees who flew into Miami last weekend for the biggest bitcoin event in history have started testing positive for Covid. Bitcoin 2021 drew crypto enthusiasts from around the world to the Mana Wynwood convention center in Miami’s arts and entertainment district. For three days, conference goers packed into crowded
0 Comments
Healthcare continues to outperform many other industries in female representation at many levels. But let’s not break out the champagne just yet — at least not until more women break through the glass ceiling and into the C-suite. Over the past decade, the number of women physicians has grown more than 43%. Unfortunately, that increase
0 Comments
More surgeons are using a software solution in the operating room that walks the team through role-specific best practices for a procedure in real time, eliminating inconsistencies that come from varied experience levels and techniques. The first ‘digital playbook’ for surgeries was developed by Chicago-based ExplORer Surgical as part of a three-part strategy: to reduce
0 Comments
Get to know yourself, and begin living a more authentic life What does it mean to live an authentic life? And how do you know if you’re being authentically you? We all deal with certain pressures, to conform and compromise, from the people around us – our peers, partners, family, friends, employers, and society as
0 Comments
KENILWORTH, N.J.–(BUSINESS WIRE) June 9, 2021 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with the United States government for molnupiravir (MK-4482). Molnupiravir is currently being evaluated in a Phase 3 clinical trial, the MOVe-OUT study, for the treatment of non-hospitalized
0 Comments
BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 6 through 11 years who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a
0 Comments